0001179110-20-000809.txt : 20200127 0001179110-20-000809.hdr.sgml : 20200127 20200127183040 ACCESSION NUMBER: 0001179110-20-000809 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20200124 FILED AS OF DATE: 20200127 DATE AS OF CHANGE: 20200127 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Dreier Ashley CENTRAL INDEX KEY: 0001614957 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-36568 FILM NUMBER: 20550957 MAIL ADDRESS: STREET 1: 15 W. SCENIC POINTE DR., STE. 100 CITY: DRAPER STATE: UT ZIP: 84020 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: HEALTHEQUITY, INC. CENTRAL INDEX KEY: 0001428336 STANDARD INDUSTRIAL CLASSIFICATION: SERVICES-BUSINESS SERVICES, NEC [7389] IRS NUMBER: 000000000 STATE OF INCORPORATION: DE FISCAL YEAR END: 0131 BUSINESS ADDRESS: STREET 1: 15 WEST SCENIC POINTE DRIVE STREET 2: SUITE 100 CITY: DRAPER STATE: UT ZIP: 84020 BUSINESS PHONE: 801-727-1000 MAIL ADDRESS: STREET 1: 15 WEST SCENIC POINTE DRIVE STREET 2: SUITE 100 CITY: DRAPER STATE: UT ZIP: 84020 FORMER COMPANY: FORMER CONFORMED NAME: HEALTHEQUITY INC DATE OF NAME CHANGE: 20080227 4 1 edgar.xml FORM 4 - X0306 4 2020-01-24 0 0001428336 HEALTHEQUITY, INC. HQY 0001614957 Dreier Ashley C/O HEALTHEQUITY, INC. 15 W. SCENIC POINTE DR., STE. 100 DRAPER UT 84020 0 1 0 0 Executive, VP, CTO and CIO Common Stock 2020-01-24 4 M 0 16250 24.36 A 53737 D Common Stock 2020-01-24 4 M 0 4000 14.00 A 57737 D Common Stock 2020-01-24 4 S 0 16194 70.8764 D 41543 D Common Stock 2020-01-24 4 S 0 4056 71.5511 D 37487 D Common Stock 2020-01-24 4 S 0 4964 70.8320 D 32523 D Common Stock 2020-01-24 4 S 0 1779 71.5964 D 30744 D Stock Option (right to buy) 24.36 2020-01-24 4 M 0 16250 0 D 2026-03-23 Common Stock 16250 16250 D Stock Option (right to buy) 14 2020-01-24 4 M 0 4000 0 D 2024-07-30 Common Stock 4000 0 D The option exercises and subsequent sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on December 9, 2019. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $70.26 to $71.25 per share. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each transaction as set forth in footnotes (2), (3), (4), and (5) to this Form 4. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $71.28 to $71.81 per share. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $70.34 to $71.32 per share. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $71.35 to $71.86 per share. The option will become exercisable as to 16,250 shares on March 23, 2020. The option is immediately exercisable /s/ Ashley Dreier 2020-01-27